Loading...
In the week ending August 18, 2025 five insiders at MaxCyte (MXCT, $1.36) bought a total of 355,000 shares for proceeds of $480.0K. Year-to-date, a total of five MaxCyte officers have purchased 355,000 shares worth $480.0K. Here are the insiders making moves:
ERCK STANLEY C, Director – bought 100,000 shares of MXCT between August 11 - 18, 2025. Total $137K.
DOUGLAS RICHARD, Director – bought 80,000 shares of MXCT between August 11 - 18, 2025. Total $111.2K.
MASOUD MAHER, President and CEO – bought 75,000 shares of MXCT between August 11 - 18, 2025. Total $102.8K.
SWIRSKY DOUGLAS J, CHIEF FINANCIAL OFFICER – bought 50,000 shares of MXCT between August 11 - 18, 2025. Total $64.5K.
BROOKE WILLIAM W, Director – bought 50,000 shares of MXCT between August 11 - 18, 2025. Total $64.5K.
MXCT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on August 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MXCT as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
MXCT moved below its 50-day moving average on July 29, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MXCT advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .
MXCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 107 cases where MXCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.760) is normal, around the industry mean (59.359). P/E Ratio (0.000) is within average values for comparable stocks, (38.307). MXCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.709). MXCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.023) is also within normal values, averaging (77.214).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MXCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices